Geographic differences in the target-controlled infusion estimated concentration of propofol: Bispectral index response curves

Canadian Journal of Anesthesia

Volumn 58, Issue 4, 2011, Pages 364-370

  Dahaba, Ashraf A ^a   Zhong, Taidi ^b   Lu, Hui Shun ^c   Bornemann, Helmar ^a   Liebmann, Markus ^a   Wilfinger, Georg ^a   Reibnegger, Gilbert ^a   Metzler, Helfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; AUSTRIA; BISPECTRAL INDEX; CHINESE; CLINICAL ARTICLE; CONSCIOUSNESS LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC ORIGIN; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INFUSION PUMP; MALE; PLASMA CONCENTRATION-TIME CURVE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; ANESTHETICS, INTRAVENOUS; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPOFOL;

EID: 79953656439     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-011-9453-2     Document Type: Article

References (25)

1. Ortolani O, Conti A, Chan YK, Sie MY, Ong GS. Comparison of propofol consumption and recovery time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia. Anaesth Intensive Care 2004; 32: 250-5. (Pubitemid 38425608)
2. Ortolani O, Conti A, Ngumi ZW, et al. Ethnic differences in propofol and fentanyl response: a comparison among Caucasians, Kenyan Africans and Brazilians. Eur J Anaesthesiol 2004; 21: 314-9. (Pubitemid 38461664)
3. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002. (Pubitemid 28463304)
4. White M, Schenkels MJ, Engbers FH, et al. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1999; 82: 333-9. (Pubitemid 29112531)
5. Xu Z, Liu F, Yue Y, et al. C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial. Anesth Analg 2009; 108: 478-83.
6. Zhang MZ, Yu Q, Huang YL, Wang SJ, Wang XR. A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol. Eur J Anaesthesiol 2007; 24: 876-81. (Pubitemid 350194899)
7. Milne SE, Troy A, Irwin MG, Kenny GN. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth 2003; 90: 127-31. (Pubitemid 36181954)
8. Irwin MG, Hui TW, Milne SE, Kenny GN. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia 2002; 57: 242-8.
9. Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8.
10. Li YH, Xu JH, Yang JJ, Tian J, Xu JG. Predictive performance of 'Diprifusor' TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia. J Zhejiang Univ Sci B 2005; 6: 43-8.
11. Coetzee JF, Glen JB, Wium CA, Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45.
12. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4. (Pubitemid 32378696)
13. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology 2000; 92: 1603-16. (Pubitemid 30412478)
14. Dahaba AA, Oettl K, von Klobucar F, Reibnegger G, List WF. End stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anesth 2002; 49: 369-74. (Pubitemid 34546167)
15. Dahaba AA, Perelman SI, Moskowitz DM, et al. Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosage. Anesthesiology 2006; 104: 950-3.
16. Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 2002; 71: 115-21. (Pubitemid 34271114)
17. Rolan PE. Plasma protein binding displacement interactions -why are they still regarded as clinically important? Br J Clin Pharmacol 1994; 37: 125-8.
18. MacKichan JJ. Protein binding drug displacement interactions fact or fiction? Clin Pharmacokinet 1989; 16: 65-73.
19. Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuchi R. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 2004; 75: 324-30. (Pubitemid 38471557)
20. Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42. (Pubitemid 29043162)
21. Takizawa E, Hiraoka H, Takizawa D, Goto F. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth 2006; 96: 179-85. (Pubitemid 43174657)
22. Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990; 48: 10-7. (Pubitemid 20236197)
23. Dahaba AA, von Klobucar F, Rehak PH, List WF. Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end stage renal failure. Can J Anesth 1999; 46: 696-700. (Pubitemid 29378695)
24. Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol - defining and illuminating the devil in the detail. Br J Anaesth 2009; 103: 26-37.
25. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82. (Pubitemid 28216859)